Overview

Long Term Effect of Somatropin in Subjects With Intrauterine Growth Retardation

Status:
Completed
Trial end date:
2003-04-30
Target enrollment:
0
Participant gender:
All
Summary
This trial is conducted in Europe. The aim of this trial is to assess the safety of long-term growth hormone treatment in growth-retarded children with intrauterine growth retardation (IUGR) enrolled in trial GHRETARD/F/1/F.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Novo Nordisk A/S
Criteria
Inclusion Criteria:

- Patients born with IUGR enrolled in trial GHRETARD/F/1/F

- Bone age below 14 years in boys and 12 years in girls

Exclusion Criteria:

- Bone age above 14 years in boys and 12 years in girls